Company intelligence / Profile preview

OB-Tools

Ownership: Private
Employees: ~7
Development stage: Other

Overview

OB‑Tools has developed the TrueLabor™ Technology, a non-invasive maternal-fetal monitor that accurately identifies, measures, and evaluates uterine contractions and fetal heart rate throughout pregnancy and labor. The system is designed to distinguish between true and false labor signs, providing safe readings even in challenging conditions. It aims to improve outcomes for mothers and babies by offering an alternative to traditional Toco systems or invasive internal monitors[1][2].

Therapeutic areas: Women's Health
Modalities: DeviceDigital health technology (signal processing)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on OB-Tools.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OB-Tools.

Explore the full profile